Clinical Trials

Neoplasm Metastasis

NCT06783140 2025-12-05

PLATINUM-CAN

Phase 2/3 Recruiting

10 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT04807816 2025-10-02

TARSARC

Phase 2 Recruiting

72 enrolled

Sarcoma

Leiomyosarcoma, Neoplasm Metastasis, Sarcoma

NCT05821556 2025-07-29

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Phase 2 Recruiting

240 enrolled

Neoplasm Metastasis

NCT06820255 2025-02-11

SELECTIO-UC

Phase 4 Recruiting

135 enrolled

Neoplasm Metastasis

NCT00128310 2023-05-31

Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

Phase 3 Completed

252 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT05854849 2023-05-11

Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC

Phase 3 Recruiting

244 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT02479230 2022-11-22

Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients

18 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01879085 2022-09-21

GemTax

Phase 1/2 Completed

37 enrolled 17 charts

Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03487016 2022-09-08

FOOTPATH

270 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02631590 2021-08-04

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

24 enrolled 11 charts

Phase 2/3 Not yet recruiting

Digestive System Neoplasms, Gallbladder Neoplasms, Neoplasm Metastasis, Cholangiocarcinoma

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

622 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT02155088 2021-04-08

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

15 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT03989310 2020-12-23

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Phase 1/2 Unknown

50 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01385956 2020-09-28

SOM 230 and Gemcitabine in Advanced Pancreatic Cancer

20 enrolled

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT04167007 2020-08-18

GEMFOX

Phase 3 Unknown

400 enrolled

Neoplasm Metastasis

NCT04361409 2020-04-28

Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

10 enrolled

GastrointestinalGynecologic

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT00390182 2020-03-18

GCC0319

Phase 1/2 Completed

38 enrolled 9 charts

Gastrointestinal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT01442662 2020-01-31

LMS03

106 enrolled

Sarcoma

Leiomyosarcoma, Neoplasm Metastasis

NCT03307148 2020-01-22

STAR_PAC

29 enrolled

Neoplasm Metastasis

NCT02106884 2019-11-06

QOLINPAC

146 enrolled 18 charts

Neoplasm Metastasis, Pancreatic Neoplasms

NCT03610100 2019-10-29

ACELARATE

Phase 2/3 Suspended

328 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT01679405 2019-09-06

BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer

Phase 1 Terminated

9 enrolled 12 charts

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT01309633 2019-07-22

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

80 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT04004234 2019-07-09

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Phase 1/2 Unknown

20 enrolled

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT00300586 2019-05-28

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Phase 3 Completed

842 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT03876574 2019-03-15

Hepatic Artery Infusion Pump for NPC Liver Metastases

16 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT02560038 2018-11-28

Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer

Phase 2 Terminated

3 enrolled 9 charts

Urinary Bladder Neoplasms, Neoplasm Metastasis

NCT02105350 2018-02-19

A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Phase 1 Withdrawn

Gallbladder Neoplasms, Neoplasm Metastasis, Recurrence

NCT00201760 2017-12-27

Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer

10 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00561119 2017-05-01

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

Phase 3 Completed

326 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01198821 2017-02-23

Gem-TABS in Unresectable Pancreatic Carcinoma

8 enrolled

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT01964534 2017-01-31

AFUGEM

114 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00696696 2016-06-30

Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer

45 enrolled 8 charts

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02761291 2016-05-16

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1 Unknown

18 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections, Multiple Acyl Coenzyme A Dehydrogenase Deficiency

NCT00556049 2016-04-21

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

72 enrolled 6 charts

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01633645 2015-09-28

Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

53 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00176241 2015-06-08

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

Phase 1 Terminated

7 enrolled

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT02132403 2015-05-01

PM-01

Phase 1 Terminated

3 enrolled

Anophthalmia with pulmonary hypoplasia, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT01472770 2014-12-04

GemCaP

49 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT01409005 2014-02-11

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

41 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00661830 2013-11-21

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

103 enrolled 18 charts

Adenocarcinoma, Neoplasm Metastasis

NCT01834183 2013-06-19

Tivozanib + Gemcitabine in Metastatic RCC

Phase 2 Withdrawn

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01161186 2012-10-11

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma

15 enrolled

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT01655628 2012-08-02

GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma

40 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT00837239 2012-07-12

Huachansu & Gemcitabine in Pancreatic Cancer

80 enrolled

Gastrointestinal Diseases, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00237575 2012-05-23

Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer

Phase 3 Terminated

100 enrolled

Urinary Bladder Neoplasms, Neoplasm Metastasis

NCT01125020 2010-05-18

Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

Phase NA Unknown

150 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00758381 2008-10-10

MAPS

114 enrolled